• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于平板电脑的前驱期阿尔茨海默病图片命名评估:一种区分轻度认知障碍与正常衰老的便捷有效工具。

Tablet-Based Assessment of Picture Naming in Prodromal Alzheimer's Disease: An Accessible and Effective Tool for Distinguishing Mild Cognitive Impairment from Normal Aging.

作者信息

Seidman Lauren, Hyman Sara, Kenney Rachel, Nsiri Avivit, Galetta Steven, Masurkar Arjun V, Balcer Laura

机构信息

New York Medical College, Valhalla, New York, USA,

Department of Neurology, NYU Grossman School of Medicine, New York, New York, USA.

出版信息

Dement Geriatr Cogn Disord. 2025 Jun 11:1-12. doi: 10.1159/000546451.

DOI:10.1159/000546451
PMID:40499520
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12240569/
Abstract

INTRODUCTION

Effective mild cognitive impairment (MCI) screening requires accessible testing. This study compared two tests for distinguishing MCI patients from controls: rapid automatized naming (RAN) for naming speed and low-contrast letter acuity (LCLA) for sensitivity to low-contrast letters.

METHODS

Two RAN tasks were used: the Mobile Universal Lexicon Evaluation System (MULES, picture naming) and the Staggered Uneven Number test (SUN, number naming). Both RAN tasks were administered on a tablet and in a paper/pencil format. The tablet format was administered using the Mobile Integrated Cognitive Kit application. LCLA was tested at 2.5% and 1.25% contrast.

RESULTS

Sixty-four participants (31 MCI, 34 controls; mean age 73.2 ± 6.8 years) were included. MCI patients were slower than controls for paper/pencil (75.0 vs. 53.6 s, p < 0.001), and tablet MULES (69.0 s vs. 50.2 s, p = 0.01). The paper/pencil SUN showed no significant difference (MCI: 59.5 s vs. controls: 59.9 s, p = 0.07) nor did the tablet SUN (MCI: 59.3 s vs. controls: 55.7 s, p = 0.36). MCI patients had worse performance on LCLA testing at 2.5% contrast (33 letters vs. 36, p = 0.04*) and 1.25% (0 letters vs. 14 letters, p < 0.001). Receiver operating characteristic (ROC) analysis showed similar performance of paper/pencil and tablet MULES in distinguishing MCI from controls (area under the ROC curve [AUC] = 0.77), outperforming both SUN (AUC = 0.63 paper, 0.59 tablet) and LCLA (2.5% contrast: AUC = 0.65, 1.25% contrast: AUC = 0.72).

CONCLUSION

The MULES, in both formats, may be a valuable screening tool for MCI.

摘要

引言

有效的轻度认知障碍(MCI)筛查需要可及的测试方法。本研究比较了两种用于区分MCI患者与对照者的测试:用于命名速度的快速自动命名(RAN)和用于低对比度字母敏感度的低对比度字母视力(LCLA)。

方法

使用了两项RAN任务:移动通用词汇评估系统(MULES,图片命名)和交错奇数测试(SUN,数字命名)。两项RAN任务均以平板电脑和纸笔形式进行。平板电脑形式使用移动综合认知套件应用程序进行管理。LCLA在2.5%和1.25%的对比度下进行测试。

结果

纳入了64名参与者(31名MCI患者,34名对照者;平均年龄73.2±6.8岁)。MCI患者在纸笔测试(75.0秒对53.6秒,p<0.001)和平板电脑MULES测试(69.0秒对50.2秒,p = 0.01)中的速度比对照者慢。纸笔形式的SUN测试无显著差异(MCI:59.5秒对对照者:59.9秒,p = 0.07),平板电脑形式的SUN测试也无显著差异(MCI:59.3秒对对照者:55.7秒,p = 0.36)。MCI患者在2.5%对比度(33个字母对36个,p = 0.04*)和1.25%对比度(0个字母对14个字母,p<0.001)的LCLA测试中表现更差。受试者工作特征(ROC)分析表明,纸笔和平板电脑形式的MULES在区分MCI与对照者方面表现相似(ROC曲线下面积[AUC]=0.77),优于SUN(纸笔AUC = 0.63,平板电脑AUC = 0.59)和LCLA(2.5%对比度:AUC = 0.65,1.25%对比度:AUC = 0.72)。

结论

两种形式的MULES都可能是用于MCI的有价值的筛查工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcfb/12240569/061a7267f5fb/dem-2025-0000-0000-546451_F05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcfb/12240569/056213d836db/dem-2025-0000-0000-546451_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcfb/12240569/b54315830fce/dem-2025-0000-0000-546451_F02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcfb/12240569/85490857ae9f/dem-2025-0000-0000-546451_F03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcfb/12240569/aebcec9ac61a/dem-2025-0000-0000-546451_F04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcfb/12240569/061a7267f5fb/dem-2025-0000-0000-546451_F05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcfb/12240569/056213d836db/dem-2025-0000-0000-546451_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcfb/12240569/b54315830fce/dem-2025-0000-0000-546451_F02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcfb/12240569/85490857ae9f/dem-2025-0000-0000-546451_F03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcfb/12240569/aebcec9ac61a/dem-2025-0000-0000-546451_F04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcfb/12240569/061a7267f5fb/dem-2025-0000-0000-546451_F05.jpg

相似文献

1
Tablet-Based Assessment of Picture Naming in Prodromal Alzheimer's Disease: An Accessible and Effective Tool for Distinguishing Mild Cognitive Impairment from Normal Aging.基于平板电脑的前驱期阿尔茨海默病图片命名评估:一种区分轻度认知障碍与正常衰老的便捷有效工具。
Dement Geriatr Cogn Disord. 2025 Jun 11:1-12. doi: 10.1159/000546451.
2
Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).用于检测轻度认知障碍(MCI)患者中阿尔茨海默病及其他痴呆症的简易精神状态检查表(MMSE)。
Cochrane Database Syst Rev. 2015 Mar 5;2015(3):CD010783. doi: 10.1002/14651858.CD010783.pub2.
3
Exploration of Rapid Automatized Naming and Standard Visual Tests in Prodromal Alzheimer Disease Detection.快速自动命名和标准视觉测试在前驱期阿尔茨海默病检测中的探索。
J Neuroophthalmol. 2022 Mar 1;42(1):79-87. doi: 10.1097/WNO.0000000000001228. Epub 2021 May 17.
4
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
5
18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代硼吡咯进行18F正电子发射断层显像以早期诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012216. doi: 10.1002/14651858.CD012216.pub2.
6
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代甲磺酸去甲肾上腺素的18F正电子发射断层显像用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.
7
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).¹⁸F - 氟代脱氧葡萄糖正电子发射断层显像(¹⁸F - FDG PET)用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD010632. doi: 10.1002/14651858.CD010632.pub2.
8
Evaluation of Digital Drawing Tests and Paper-and-Pencil Drawing Tests for the Screening of Mild Cognitive Impairment and Dementia: A Systematic Review and Meta-analysis of Diagnostic Studies.数字绘画测试和纸笔绘画测试在轻度认知障碍和痴呆筛查中的评估:系统评价和诊断研究的荟萃分析。
Neuropsychol Rev. 2022 Sep;32(3):566-576. doi: 10.1007/s11065-021-09523-2. Epub 2021 Oct 16.
9
Vitamin E for Alzheimer's dementia and mild cognitive impairment.维生素E用于治疗阿尔茨海默病性痴呆和轻度认知障碍。
Cochrane Database Syst Rev. 2017 Apr 18;4(4):CD002854. doi: 10.1002/14651858.CD002854.pub5.
10
Folic acid with or without vitamin B12 for cognition and dementia.叶酸联合或不联合维生素B12对认知及痴呆的影响
Cochrane Database Syst Rev. 2003(4):CD004514. doi: 10.1002/14651858.CD004514.

本文引用的文献

1
Environmental risk factors for all-cause dementia, Alzheimer's disease dementia, vascular dementia, and mild cognitive impairment: An umbrella review and meta-analysis.全因性痴呆、阿尔茨海默病性痴呆、血管性痴呆和轻度认知障碍的环境危险因素:一项综合综述和荟萃分析。
Environ Res. 2025 Apr 1;270:121007. doi: 10.1016/j.envres.2025.121007. Epub 2025 Jan 29.
2
Biomarker-based staging of Alzheimer disease: rationale and clinical applications.基于生物标志物的阿尔茨海默病分期:原理与临床应用。
Nat Rev Neurol. 2024 Apr;20(4):232-244. doi: 10.1038/s41582-024-00942-2. Epub 2024 Mar 1.
3
Visual processing speed and its association with future dementia development in a population-based prospective cohort: EPIC-Norfolk.
基于人群的前瞻性队列研究:视觉处理速度及其与未来痴呆发展的关系。EPIC-Norfolk
Sci Rep. 2024 Feb 29;14(1):5016. doi: 10.1038/s41598-024-55637-x.
4
Bayesian estimation for the accuracy of three neuropsychological tests in detecting Alzheimer's disease and mild cognitive impairment: a retrospective analysis of the ADNI database.贝叶斯估计三种神经心理学测试诊断阿尔茨海默病和轻度认知障碍准确性:ADNI 数据库的回顾性分析。
Eur J Med Res. 2023 Oct 12;28(1):427. doi: 10.1186/s40001-023-01265-6.
5
Eye-tracking paradigms for the assessment of mild cognitive impairment: a systematic review.用于评估轻度认知障碍的眼动追踪范式:一项系统综述
Front Psychol. 2023 Jul 20;14:1197567. doi: 10.3389/fpsyg.2023.1197567. eCollection 2023.
6
The MINT Sprint 2.0: A picture naming test for detection of naming impairments in Alzheimer's disease and in preclinical AD.MINT 冲刺 2.0:一种图片命名测试,用于检测阿尔茨海默病和临床前 AD 中的命名障碍。
Alzheimers Dement. 2024 Jan;20(1):112-123. doi: 10.1002/alz.13381. Epub 2023 Jul 19.
7
CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease.脑脊液生物标志物在轻度认知障碍和阿尔茨海默病的早期诊断中的应用。
Int J Mol Sci. 2023 May 19;24(10):8976. doi: 10.3390/ijms24108976.
8
Where's the Vision? The Importance of Visual Outcomes in Neurologic Disorders: The 2021 H. Houston Merritt Lecture.视野在哪里?神经疾病中视觉结果的重要性:2021 年 H. 休斯顿·梅里特讲座。
Neurology. 2023 Jan 31;100(5):244-253. doi: 10.1212/WNL.0000000000201490. Epub 2022 Dec 15.
9
Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer's Disease.扫视缩短可作为一种易于使用的生物标志物,用于检测阿尔茨海默病的风险。
J Alzheimers Dis. 2022;88(2):609-618. doi: 10.3233/JAD-215551.
10
A Color-Picture Version of Boston Naming Test Outperformed the Black-and-White Version in Discriminating Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease.在区分遗忘型轻度认知障碍和轻度阿尔茨海默病方面,波士顿命名测试的彩色图片版比黑白版表现更优。
Front Neurol. 2022 Apr 25;13:884460. doi: 10.3389/fneur.2022.884460. eCollection 2022.